Recombinant Human GLI1 Protein，His

GLI1, a key transcription factor in the Hedgehog signaling pathway, plays a critical role in embryonic development and tissue homeostasis. Abnormal regulation of GLI1 is implicated in various human diseases, particularly cancer, where it is often overexpressed, leading to unchecked cellular proliferation and survival. Understanding GLI1's function has significant therapeutic implications, especially in targeting Hedgehog pathway-related malignancies. Researchers have been increasingly focused on characterizing GLI1’s structure and function through recombinant protein studies. By utilizing techniques such as cloning, expression, and purification of GLI1, scientists aim to elucidate its mechanisms of action, interactions with other proteins, and the impact of post-translational modifications. These studies contribute to a deeper understanding of the molecular underpinnings of diseases associated with GLI1 dysregulation and pave the way for developing potential interventions, including small molecule inhibitors or gene therapies. Furthermore, recombinant GLI1 proteins serve as valuable tools in drug discovery, allowing for the screening of compounds that can modulate its activity. Overall, the research on recombinant GLI1 is essential for advancing our knowledge of cellular signaling pathways and their implications in health and disease.